| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.5301 | 35 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.8223 | 40 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.8608 | 41 |
| GSM780719 | Untreated after 4 days (C1_2) | 47.5707 | 39 |
| GSM780720 | Untreated after 4 days (C2_2) | 44.2465 | 23 |
| GSM780721 | Untreated after 4 days (C3_2) | 42.9232 | 17 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.7556 | 44 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 47.6843 | 40 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 44.044 | 22 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 44.7322 | 26 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.207 | 18 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.0188 | 32 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.4659 | 43 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.6228 | 20 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.9957 | 27 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.4327 | 39 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 47.6365 | 40 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.9574 | 32 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 48.1991 | 42 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 40.0707 | 7 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 45.3721 | 29 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 43.394 | 19 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 47.0426 | 37 |